ABBOTT LABORATORIES Treasury Stock, Value
ABBOTT LABORATORIES (ABT) had Treasury Stock, Value of $10.79 billion as of 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2016-11-03
- 2016-09-30: Treasury Stock, Value $10.79B.
- 2016-06-30: Treasury Stock, Value $10.82B.
- 2016-03-31: Treasury Stock, Value $10.82B.
- 2015-12-31: Treasury Stock, Value $10.62B.
| Period end | Treasury Stock, Value | Treasury Stock, Value as first filed |
|---|---|---|
| 2016-09-30 | $10.79B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $10.82B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $10.82B 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $10.62B 10-Q · filed 2016-11-03 | |
| 2015-09-30 | $9.69B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $9.72B 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $9.72B 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $8.68B 10-K · filed 2016-02-19 | |
| 2014-09-30 | $8.68B 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $8.71B 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $8.71B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $6.84B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $6.81B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $6.49B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $6.19B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $5.59B 10-K · filed 2014-02-21 | $5.59B 10-K · filed 2013-02-15 |
| 2012-09-30 | $4.98B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $5.01B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $4.30B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $3.69B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $3.69B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $3.71B 10-Q · filed 2011-08-04 | |
| 2011-03-31 | $3.72B 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $3.92B 10-K · filed 2013-02-15 | |
| 2010-09-30 | $3.92B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $3.94B 10-Q · filed 2010-08-05 | |
| 2010-03-31 | $3.95B 10-Q · filed 2010-05-04 | |
| 2009-12-31 | $3.31B 10-K · filed 2012-02-21 | |
| 2009-09-30 | $3.32B 10-Q · filed 2009-11-06 | |
| 2009-06-30 | $3.34B 10-Q · filed 2009-08-07 | |
| 2008-12-31 | $2.63B 10-K · filed 2011-02-18 | |
| 2007-12-31 | $1.21B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |